FDA Registration
Active
🇺🇸 United States
Rubella IgM AccuLite® CLIA Test System (Ref 6475-300A and 6475-300B)
Reg #: 2020726
·
FEI: 2020726
·
Expires 2025
Products
1
Proprietary Names
4
Establishment Types
1
Classifications
1
Registration Details
- Registration Name
- MONOBIND, INC.
- Registration Number
- 2020726
- FEI Number
- 2020726
- Status
- Active
- Expiry Year
- 2025
- Initial Importer
- No
- Address
- 100 N. POINTE DR.
- City
- Lake Forest
- State
- CA
- ZIP
- 92630
- Country
- US
Owner / Operator
- Firm Name
- MONOBIND, INC.
- Operator Number
- 2020726
- Address
- 100 N. POINTE DR., --
- City
- Lake Forest
- State
- CA
- Postal Code
- 92630
- Country
- US
- Correspondent
- Alicia Jerome
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Enzyme Linked Immunoabsorbent Assay, Rubella | LFX | Class 2 | Microbiology | No | 2022-04-20 |
Proprietary Names
Rubella IgM AccuLite® CLIA Test System (Ref 6475-300A and 6475-300B)
Rubella IgG AccuBind® ELISA Test System (Ref 6325-300A and 6325-300B)
Rubella IgM AccuBind® ELISA Test System (Ref 6425-300A and 6425-300B)
Rubella IgG AccuLite® CLIA Test System (Ref 6375-300A and 6375-300B)
Establishment Types
Manufacture Device in the United States for Export Only